These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 29690903)

  • 21. Fluvastatin attenuates hepatic steatosis-induced fibrogenesis in rats through inhibiting paracrine effect of hepatocyte on hepatic stellate cells.
    Chong LW; Hsu YC; Lee TF; Lin Y; Chiu YT; Yang KC; Wu JC; Huang YT
    BMC Gastroenterol; 2015 Feb; 15():22. PubMed ID: 25886887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential Lipotoxic Effects of Palmitate and Oleate in Activated Human Hepatic Stellate Cells and Epithelial Hepatoma Cells.
    Hetherington AM; Sawyez CG; Zilberman E; Stoianov AM; Robson DL; Borradaile NM
    Cell Physiol Biochem; 2016; 39(4):1648-62. PubMed ID: 27626926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatic chemerin mRNA expression is reduced in human nonalcoholic steatohepatitis.
    Pohl R; Haberl EM; Rein-Fischboeck L; Zimny S; Neumann M; Aslanidis C; Schacherer D; Krautbauer S; Eisinger K; Weiss TS; Buechler C
    Eur J Clin Invest; 2017 Jan; 47(1):7-18. PubMed ID: 27797398
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CCL20 induced by visfatin in macrophages via the NF-κB and MKK3/6-p38 signaling pathways contributes to hepatic stellate cell activation.
    Heo YJ; Choi SE; Lee N; Jeon JY; Han SJ; Kim DJ; Kang Y; Lee KW; Kim HJ
    Mol Biol Rep; 2020 Jun; 47(6):4285-4293. PubMed ID: 32418112
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sorafenib reduces steatosis-induced fibrogenesis in a human 3D co-culture model of non-alcoholic fatty liver disease.
    Romualdo GR; Da Silva TC; de Albuquerque Landi MF; Morais JÁ; Barbisan LF; Vinken M; Oliveira CP; Cogliati B
    Environ Toxicol; 2021 Feb; 36(2):168-176. PubMed ID: 32918399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disturbed Vitamin A Metabolism in Non-Alcoholic Fatty Liver Disease (NAFLD).
    Saeed A; Dullaart RPF; Schreuder TCMA; Blokzijl H; Faber KN
    Nutrients; 2017 Dec; 10(1):. PubMed ID: 29286303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Trajectories of Liver Fibrosis and Gene Expression Profiles in Nonalcoholic Fatty Liver Disease Associated With Diabetes.
    Sako S; Takeshita Y; Takayama H; Goto H; Nakano Y; Ando H; Tsujiguchi H; Yamashita T; Arai K; Kaneko S; Nakamura H; Harada K; Honda M; Takamura T
    Diabetes; 2023 Sep; 72(9):1297-1306. PubMed ID: 37343270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nutrigenomics analysis reveals that copper deficiency and dietary sucrose up-regulate inflammation, fibrosis and lipogenic pathways in a mature rat model of nonalcoholic fatty liver disease.
    Tallino S; Duffy M; Ralle M; Cortés MP; Latorre M; Burkhead JL
    J Nutr Biochem; 2015 Oct; 26(10):996-1006. PubMed ID: 26033743
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dietary modification dampens liver inflammation and fibrosis in obesity-related fatty liver disease.
    Larter CZ; Yeh MM; Haigh WG; Van Rooyen DM; Brooling J; Heydet D; Nolan CJ; Teoh NC; Farrell GC
    Obesity (Silver Spring); 2013 Jun; 21(6):1189-99. PubMed ID: 23666886
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extracellular Vesicles in the Development of the Non-Alcoholic Fatty Liver Disease: An Update.
    Dorairaj V; Sulaiman SA; Abu N; Abdul Murad NA
    Biomolecules; 2020 Oct; 10(11):. PubMed ID: 33143043
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of lncRNA HULC improves hepatic fibrosis and hepatocyte apoptosis by inhibiting the MAPK signaling pathway in rats with nonalcoholic fatty liver disease.
    Shen X; Guo H; Xu J; Wang J
    J Cell Physiol; 2019 Aug; 234(10):18169-18179. PubMed ID: 30908654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MiR-146a-5p suppresses activation and proliferation of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis through directly targeting Wnt1 and Wnt5a.
    Du J; Niu X; Wang Y; Kong L; Wang R; Zhang Y; Zhao S; Nan Y
    Sci Rep; 2015 Nov; 5():16163. PubMed ID: 26537990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. β-Klotho gene variation is associated with liver damage in children with NAFLD.
    Dongiovanni P; Crudele A; Panera N; Romito I; Meroni M; De Stefanis C; Palma A; Comparcola D; Fracanzani AL; Miele L; Valenti L; Nobili V; Alisi A
    J Hepatol; 2020 Mar; 72(3):411-419. PubMed ID: 31655133
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CerS5 deficiency promotes liver fibrosis development in non-alcoholic fatty liver disease.
    Chen J; Hao Y; Xu P; Bian D; Han L; Wu X; Zhuang Z; Wang J; Luo Y
    Biochem Biophys Res Commun; 2023 Jul; 667():120-126. PubMed ID: 37216827
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of herbal composition Gambigyeongsinhwan (4) on hepatic steatosis and inflammation in Otsuka Long-Evans Tokushima fatty rats and HepG2 cells.
    Yoon S; Kim J; Lee H; Lee H; Lim J; Yang H; Shin SS; Yoon M
    J Ethnopharmacol; 2017 Jan; 195():204-213. PubMed ID: 27845265
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A nonalcoholic fatty liver disease model in human induced pluripotent stem cell-derived hepatocytes, created by endoplasmic reticulum stress-induced steatosis.
    Parafati M; Kirby RJ; Khorasanizadeh S; Rastinejad F; Malany S
    Dis Model Mech; 2018 Sep; 11(9):. PubMed ID: 30254132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. AEBP1 expression increases with severity of fibrosis in NASH and is regulated by glucose, palmitate, and miR-372-3p.
    Gerhard GS; Hanson A; Wilhelmsen D; Piras IS; Still CD; Chu X; Petrick AT; DiStefano JK
    PLoS One; 2019; 14(7):e0219764. PubMed ID: 31299062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. USP33 promotes nonalcoholic fatty acid disease-associated fibrosis in gerbils via the c-myc signaling.
    Ke X; Hu H; Peng Q; Ying H; Chu X
    Biochem Biophys Res Commun; 2023 Aug; 669():68-76. PubMed ID: 37267862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phosphatidylethanolamines Are Associated with Nonalcoholic Fatty Liver Disease (NAFLD) in Obese Adults and Induce Liver Cell Metabolic Perturbations and Hepatic Stellate Cell Activation.
    Shama S; Jang H; Wang X; Zhang Y; Shahin NN; Motawi TK; Kim S; Gawrieh S; Liu W
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674549
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Geranylgeranyl diphosphate synthase (GGPPS) regulates non-alcoholic fatty liver disease (NAFLD)-fibrosis progression by determining hepatic glucose/fatty acid preference under high-fat diet conditions.
    Liu J; Jiang S; Zhao Y; Sun Q; Zhang J; Shen D; Wu J; Shen N; Fu X; Sun X; Yu D; Chen J; He J; Shi T; Ding Y; Fang L; Xue B; Li C
    J Pathol; 2018 Nov; 246(3):277-288. PubMed ID: 29971772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.